Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Processa Pharmaceuticals, Inc. (PCSA)  
$0.23 0.00 (0.00%) as of 4:30 Fri 1/19


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 10,570,000
Market Cap: 2.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.182 - $0.835
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Processa Pharmaceuticals is a biopharmaceutical company focused on the development of drug products for patients who have unmet medical need. Co. 's drug pipelines are: PCS499, which is an oral tablet that is an analog of one of the major metabolites of pentoxifylline; PCS12852, which is a potent and 5-hydroxytryptamine 4 receptor agonist; PCS3117, which is an analog of the endogenous nucleoside, cytidine, and an analog of the cancer drug gemcitabine; PCS6422, which is an oral inhibitor of dihydropyrimidine dehydrogenase, the enzyme that metabolizes a common chemotherapy drug known as 5-FU, into inactive metabolites; and PCS11T, which is a lipophilic anti-cancer pro-drug.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 63,000 63,000 103,000 185,000
Total Buy Value $160,099 $160,099 $192,099 $235,286
Total People Bought 4 4 4 4
Total Buy Transactions 6 6 7 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 129
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Young David Pres. Research & Development   •       •      –    2024-02-07 4 B $2.45 $51,526 D/D 21,000 79,387 0.01     -
   Young David Pres. Research & Development   •       •      –    2024-02-06 4 B $2.53 $50,504 D/D 20,000 58,387 0.01     -
   Lin Patrick Chief Business - Strategy Off   •       •      –    2024-02-01 4 B $2.40 $3,600 D/D 1,500 27,478 0.01     -
   Lin Patrick Chief Business - Strategy Off   •       •      –    2024-01-31 4 B $2.37 $5,925 D/D 2,500 25,978 0.01     -
   Ng George K Chief Executive Officer   •       •      –    2024-01-30 4 B $2.70 $27,000 I/I 10,000 20,000 0.01     -
   Yorke Justin W   •       •      –    2024-01-30 4 B $2.69 $21,544 I/I 8,000 31,232 0.01     -
   Stanker James H Chief Financial Officer   •       •      –    2024-01-01 4 D $2.79 $1,445 D/D (518) 6,120     -
   Stanker James H Chief Financial Officer   •       •      –    2024-01-01 4 OE $0.00 $0 D/D 1,675 6,638     -
   Lin Patrick Chief Business - Strategy Off   •       •      –    2024-01-01 4 D $2.79 $1,504 D/D (539) 28,614     -
   Lin Patrick Chief Business - Strategy Off   •       •      –    2024-01-01 4 OE $0.00 $0 D/D 1,675 29,153     -
   Young David Pres. Research & Development   •       •      –    2024-01-01 4 D $2.79 $1,445 D/D (518) 80,544     -
   Young David Pres. Research & Development   •       •      –    2024-01-01 4 OE $0.00 $0 D/D 1,675 81,062     -
   Guy Wendy Chief Administrative Officer   •       •      –    2024-01-01 4 D $2.79 $1,027 D/D (368) 11,433     -
   Guy Wendy Chief Administrative Officer   •       •      –    2024-01-01 4 OE $0.00 $0 D/D 1,675 11,801     -
   Bigora Sian Chief Development Officer   •       •      –    2024-01-01 4 D $2.79 $1,027 D/D (368) 21,458     -
   Bigora Sian Chief Development Officer   •       •      –    2024-01-01 4 OE $0.00 $0 D/D 1,675 21,826     -
   Yorke Justin W   •       •      –    2023-11-21 4 D $0.00 $0 I/I (55,267) 464,623     -
   Yorke Justin W   •       •      –    2023-10-12 4/A A $0.30 $1,800 D/D 6,000 74,729     -
   Guy Wendy Chief Administrative Officer   •       •      –    2023-10-12 4 A $0.34 $5,022 D/D 14,771 202,517     -
   Lin Patrick Chief Business - Strategy Off   •       •      –    2023-10-12 4 A $0.32 $1,600 D/D 5,000 469,535     -
   Young David Pres. Research & Development   •       •       •   2023-10-12 4 A $0.29 $45,030 D/D 155,277 767,701     -
   Stanker James H Chief Financial Officer   •       •      –    2023-10-12 4 A $0.33 $4,950 D/D 15,000 99,250     -
   Ng George K Chief Executive Officer   •       •      –    2023-10-12 4 A $0.25 $25,000 D/D 100,000 200,000     -
   Yorke Justin W   •       •      –    2023-10-12 4 A $0.30 $1,800 D/D 6,000 75,729     -
   Yorke Justin W   •       •      –    2023-10-10 4 A $0.21 $2,520 D/D 12,000 69,729     -
  129 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us